Search research articles
Contact Us
Filters
Showing results (101-110 of 106) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 106 results.
Biochemical and Biophysical Research Communications
|
October 11, 2005
In vivo functional characterization of the SARS-Coronavirus 3a protein in Drosophila
S L Alan Wong, Yiwei Chen, Chak Ming Chan, et al.
Journal of Medicinal Chemistry
|
April 18, 2018
N<sup>ε</sup>-Acryloyllysine Piperazides as Irreversible Inhibitors of Transglutaminase 2: Synthesis, Structure-Activity Relationships, and Pharmacokinetic Profiling
Robert Wodtke, Christoph Hauser, Gloria Ruiz-Gómez, et al.
Cell Systems
|
February 19, 2026
What problem do you hope bioengineering or synthetic biology approaches will enable us to tackle in the next decade?
Sang Yup Lee, Alan Wong, Tom Ellis, et al.
Mucosal Immunology
|
August 21, 2020
A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation
Julia Schanin, Simon Gebremeskel, Wouter Korver, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 18, 2025
Treatment Selection and Prioritization for the EJS ACT-PD MAMS Trial Platform
Cristina Gonzalez-Robles, Dilan Athauda, Thomas R Barber, et al.
Lancet (London, England)
|
February 7, 2025
Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial
Nirosen Vijiaratnam, Christine Girges, Grace Auld, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 106) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 106 results.
Biochemical and Biophysical Research Communications
|
October 11, 2005
In vivo functional characterization of the SARS-Coronavirus 3a protein in Drosophila
S L Alan Wong, Yiwei Chen, Chak Ming Chan, et al.
Journal of Medicinal Chemistry
|
April 18, 2018
N<sup>ε</sup>-Acryloyllysine Piperazides as Irreversible Inhibitors of Transglutaminase 2: Synthesis, Structure-Activity Relationships, and Pharmacokinetic Profiling
Robert Wodtke, Christoph Hauser, Gloria Ruiz-Gómez, et al.
Cell Systems
|
February 19, 2026
What problem do you hope bioengineering or synthetic biology approaches will enable us to tackle in the next decade?
Sang Yup Lee, Alan Wong, Tom Ellis, et al.
Mucosal Immunology
|
August 21, 2020
A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation
Julia Schanin, Simon Gebremeskel, Wouter Korver, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 18, 2025
Treatment Selection and Prioritization for the EJS ACT-PD MAMS Trial Platform
Cristina Gonzalez-Robles, Dilan Athauda, Thomas R Barber, et al.
Lancet (London, England)
|
February 7, 2025
Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial
Nirosen Vijiaratnam, Christine Girges, Grace Auld, et al.
Page
of 11